BioProcess International, Boston

Sep 23-26, 2024

Hynes Convention Center, Boston, USA

Meet us at Booth #837

Speak to our Expert

I agree to receive updates from Aurigene

* I agree and accept the Privacy Policy and Terms of Use of this website.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The Aurigene expertise

Aurigene Pharmaceutical Services Limited is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides and oligonucleotides. Large molecule discovery services include ADC, mAb, mRNA, CART-T as well as development services in mAb and protein therapeutics.

About BioProcess International 2024

BioProcess International 2024 is the premier event for biopharmaceutical development and production, bringing together over 3,200 experts from 40+ countries. Covering all aspects of biopharmaceutical development, from innovative science to commercial manufacturing, the event facilitates extensive networking with 250+ exhibitors and industry leaders.

It focuses on collaborative learning and innovative solutions, offering insights into the latest advancements in bioprocessing, including new technologies, automation, digitalization, and strategies for improving process efficiency and product quality.

BioProcess International 2024 is an ideal platform for professionals to stay at the forefront of biopharmaceutical development, connect with industry leaders, and explore opportunities for collaboration and growth.

Services we Offer

Biotherapeutics CDMO

Aurigene Pharmaceutical Services provides a wide range of high-quality and flexible scale development and manufacturing services for Biotherapeutics and Viral vectors. We are expanding our Biotherapeutics services, with a focus on mono-clonal antibodies(mAbs), therapeutic proteins and viral vectors. We are developing a facility which will meet the process development and clinical supplies needs of global biotech companies. The new facility is based on a state-of-the-art design concept, allowing maximum flexibility for a multi-product, multi-platform offering across proteins, mAbs, and viral vectors. We offer exclusive access to an established large-scale GMP manufacturing facility with a drug substance capacity of 15kl and fill-finish capabilities making it possible to provide commercial quantities seamlessly.

Biotherapeutics Discovery

We offer Biotherapeutics discovery services across a wide range of therapeutic modalities or drug classes, supported by our disease and target area expertise. Aurigene has strong foundation in biotherapeutics discovery and offer end-to-end and high-quality services for Proteins, mAbs and Viral vectors. At the core of our services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities.

Pharmaceutical Drug Development Services

End-to-end services for small molecules

Aurigene provides end-to-end small molecules services across the drug life cycle. We offer integrated and standalone solutions in drug discovery for Chemistry and Biology. We provide a wide range of pharmaceutical drug development services for pre-clinical and clinical trials I, II and III wherein we synthesize New Chemical Entity (NCE) from few grams for efficacy and toxicology studies to multi-kilogram for clinical trial studies. We offer expertise in multiple technology platforms like HPAPI, peptide, PROTAC, mPEG, oligonucleotides etc. These can be offered from GLP compliant and cGMP environment to meet the client requirements. Our pharmaceutical drug manufacturing services offer a wide range of manufacturing services from a few kilos to multi tons of cGMP manufacturing of Key Starting Material (KSM)/ Registered Starting Materials (RSM), advanced intermediates, APIs and finished formulations. We have manufacturing plants across the globe, with our facilities located in India, the UK and Mexico.

Meet our Experts

We are excited to meet you and explore potential opportunities for collaboration and partnership. To schedule a meeting with us, simply provide us with your information and we will be in touch to arrange a time that works for you. We are excited to connect with you and explore how we can work together to drive success in the industry.

Dr. Roger Lias

Global Commercial Head - NBE

Jenny Yip

Business Head - Biologics, North America

Advantages to work with Aurigene